Hedenus M - Search Results

1

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M. Wahlin A, et al. Among authors: hedenus m. Eur J Haematol. 2009 Aug;83(2):99-107. doi: 10.1111/j.1600-0609.2009.01256.x. Epub 2009 Apr 6. Eur J Haematol. 2009. PMID: 19385987

2

Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia.

Wahlin A, Brinch L, Hörnsten P, Evensen SA, Oberg G, Simonsson B, Hedenus M. Wahlin A, et al. Among authors: hedenus m. Eur J Haematol. 1997 Apr;58(4):233-40. doi: 10.1111/j.1600-0609.1997.tb01660.x. Eur J Haematol. 1997. PMID: 9186533 Clinical Trial.

3

More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.

Höglund M, Brune M, Sallerfors B, Ahlgren T, Billström R, Hedenus M, Markevärn B, Nilsson B, Simonsson B, Stockelberg D, Wahlin A. Höglund M, et al. Among authors: hedenus m. Bone Marrow Transplant. 2003 Dec;32(12):1119-24. doi: 10.1038/sj.bmt.1704294. Bone Marrow Transplant. 2003. PMID: 14647265 Clinical Trial.

4

Mitoxantrone and cytarabine versus daunorubicin and cytarabine in previously untreated patients with acute myeloid leukemia.

Wahlin A, Hörnsten P, Hedenus M, Malm C. Wahlin A, et al. Among authors: hedenus m. Cancer Chemother Pharmacol. 1991;28(6):480-3. doi: 10.1007/BF00685827. Cancer Chemother Pharmacol. 1991. PMID: 1934252 Clinical Trial.

5

Impact of epoetin-beta on survival of patients with lymphoproliferative malignancies: long-term follow up of a large randomized study.

Osterborg A, Brandberg Y, Hedenus M. Osterborg A, et al. Among authors: hedenus m. Br J Haematol. 2005 Apr;129(2):206-9. doi: 10.1111/j.1365-2141.2005.05440.x. Br J Haematol. 2005. PMID: 15813848 Free article.

6

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.

Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J. Gruber A, et al. Among authors: hedenus m. Leuk Res. 2003 Apr;27(4):323-8. doi: 10.1016/s0145-2126(02)00181-9. Leuk Res. 2003. PMID: 12531223 Clinical Trial.

7

Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG).

Wisløff F, Gimsing P, Hedenus M, Hippe E, Palva I, Talstad I, Turesson I, Westin J. Wisløff F, et al. Among authors: hedenus m. Eur J Haematol. 1992 Feb;48(2):70-4. doi: 10.1111/j.1600-0609.1992.tb00568.x. Eur J Haematol. 1992. PMID: 1547878 Clinical Trial.

8

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study.

Hedenus M, Adriansson M, San Miguel J, Kramer MH, Schipperus MR, Juvonen E, Taylor K, Belch A, Altés A, Martinelli G, Watson D, Matcham J, Rossi G, Littlewood TJ; Darbepoetin Alfa 20000161 Study Group. Hedenus M, et al. Br J Haematol. 2003 Aug;122(3):394-403. doi: 10.1046/j.1365-2141.2003.04448.x. Br J Haematol. 2003. PMID: 12877666 Free article. Clinical Trial.

9

Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies.

Hedenus M, Hansen S, Taylor K, Arthur C, Emmerich B, Dewey C, Watson D, Rossi G, Osterborg A; Darbepoetin alfa 990114 Study Group. Hedenus M, et al. Br J Haematol. 2002 Oct;119(1):79-86. doi: 10.1046/j.1365-2141.2002.03774.x. Br J Haematol. 2002. PMID: 12358906 Free article. Clinical Trial.

10

Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG).

Gimsing P, Bjerrum OW, Brandt E, Ellegaard J, Evensen SA, Hansen MM, Hedenus M, Hippe E, Keldsen N, Palva I, et al. Gimsing P, et al. Among authors: hedenus m. Br J Haematol. 1991 Jan;77(1):73-9. doi: 10.1111/j.1365-2141.1991.tb07951.x. Br J Haematol. 1991. PMID: 1998599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page